R Viswanathan, P U Rao, M Dusaj, D K Sarkar, U S Bhakta. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAntitubercular Agents/therapeutic useBody WeightHumansRifampin/administration & dosageRifampin/therapeutic useSputum/microbiologyTuberculosis, Pulmonary/drug therapy
Substances: See more » Antitubercular AgentsRifampin
Year: 1970 PMID: 5506677
Source DB: PubMed Journal: Indian J Med Res ISSN: 0971-5916 Impact factor: 2.375